PFE Fair Price
$72.31
Overvalued by 2.3%
To display the fair price of a share, you need to be a member of Bulios Black.
My Notes
Začít psátFeed
Read More
BioNTech $BNTX
BioNTech reported its results yesterday.
This company focuses and specializes in the development and research of immunotherapeutic drugs targeting the treatment of cancer and infectious diseases.
It is also known for the development and production of the COVID-19 vaccine with Pfizer.
Results for the first quarter of this year :
Revenues : EUR 1.28 billion, first...
Read more
Zobrazit další komentáře
Read More
Read more
Pfizer $PFE
Pfizer reported its quarterly results yesterday.
Sector : Pharmaceuticals.
Focus, specialization : production of drugs for humans and animals and the company also focuses on fighting various diseases such as : cancer, diabetes or Alzheimer's disease.
Products : Viagra or the vaccine against COVID-19.
Results :
Revenues : $18.3 billion
Earnings per share : $1.23
...Read more
Read More
After today's $PFE results, investors are likely to be tough on even competitor $CVS, which will report its results tomorrow before the market opens. So I expect a pullback, which I will use to increase my position. Anything around $70 is a nice price in my opinion. In fact, I don't think $CVS should come up with surprisingly good results.
Zobrazit další komentáře
I don't follow pharmaceutical companies much. Occasionally you can find nice ones that come up with a discovery (drug, method). Unfortunately, I've been burned by such startups. I don't know $CVS but I might look into a pharmaceutical company.
I see that even if the covid ball is not solved so nice numbers cg to everyone who holds 💪 yesterday a lot of titles showed us that they are not written off yet